Mark Price

1.1k total citations
59 papers, 729 citations indexed

About

Mark Price is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Mark Price has authored 59 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Mark Price's work include Lung Cancer Diagnosis and Treatment (4 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Mark Price is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Mark Price collaborates with scholars based in United States, United Kingdom and Germany. Mark Price's co-authors include Robert M. Pearl, G.A. Kerkut, Sheri Fehnel, Glenn D. Goldstein, Mark W. Frank, Emmanuel Saez, Malcolm J. York, Dana DiBenedetti, James A. Kaye and Peter Johnston and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Mark Price

58 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Price United States 17 129 115 105 103 96 59 729
Hong Jia China 15 119 0.9× 107 0.9× 53 0.5× 54 0.5× 169 1.8× 42 934
Yo Han Lee South Korea 17 155 1.2× 220 1.9× 94 0.9× 44 0.4× 142 1.5× 85 1.1k
Hiroyuki Sakamaki Japan 18 104 0.8× 158 1.4× 165 1.6× 79 0.8× 149 1.6× 82 1.2k
Dingyun You China 18 190 1.5× 158 1.4× 119 1.1× 131 1.3× 292 3.0× 74 1.1k
Hang Fu China 16 120 0.9× 135 1.2× 103 1.0× 68 0.7× 309 3.2× 77 1.5k
Pensée Wu United Kingdom 21 191 1.5× 127 1.1× 160 1.5× 116 1.1× 324 3.4× 67 2.2k
Zhigang Wu China 16 58 0.4× 81 0.7× 84 0.8× 85 0.8× 223 2.3× 70 704
Lauren Collins United States 12 138 1.1× 73 0.6× 127 1.2× 184 1.8× 180 1.9× 39 1.1k
Ewelina Biskup China 16 252 2.0× 61 0.5× 99 0.9× 88 0.9× 269 2.8× 60 929

Countries citing papers authored by Mark Price

Since Specialization
Citations

This map shows the geographic impact of Mark Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Price more than expected).

Fields of papers citing papers by Mark Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Price. The network helps show where Mark Price may publish in the future.

Co-authorship network of co-authors of Mark Price

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Price. A scholar is included among the top collaborators of Mark Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Price. Mark Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Virginia, et al.. (2025). Diagnosis and Monitoring Pathways Using Non‐Invasive Tests in Patients With Alpha‐1 Antitrypsin Deficiency‐Associated Liver Disease: Results From an Expert Delphi Panel. United European Gastroenterology Journal. 13(8). 1446–1455. 1 indexed citations
2.
Dobler, Gerhard, Ava Easton, Guntis Karelis, et al.. (2024). Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel. Ticks and Tick-borne Diseases. 16(1). 102431–102431. 2 indexed citations
3.
4.
Simeone, F. Joseph, et al.. (2023). Postoperative imaging of cartilage: where are we in 2023?. SHILAP Revista de lepidopterología. 4(1). 100150–100150. 4 indexed citations
5.
Wabitsch, Martin, Sheri Fehnel, Usha G. Mallya, et al.. (2022). Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies. Advances in Therapy. 39(4). 1772–1783. 22 indexed citations
6.
Price, Mark, et al.. (2021). Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors. Journal of Patient-Reported Outcomes. 5(1). 82–82. 1 indexed citations
7.
8.
Price, Mark, Arliene Ravelo, Elisa S. Weiss, et al.. (2019). Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: Results from a national patient advocacy survey.. Journal of Clinical Oncology. 37(15_suppl). e18198–e18198. 1 indexed citations
9.
Andreas, Stefan, C. Chouaïd, Sarah Danson, et al.. (2018). Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 124. 298–309. 37 indexed citations
10.
11.
Hauber, Brett, Mark Price, Daniel Wolin, et al.. (2017). Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey. Supportive Care in Cancer. 26(1). 251–260. 11 indexed citations
12.
Lewis, Sandy, Mark Price, Seamus O’Brien, et al.. (2014). Development of a Scale to Assess Performance Following Primary Total Knee Arthroplasty. Value in Health. 17(4). 350–359. 22 indexed citations
13.
14.
Gold, Deborah T., Rob Horne, Cheryl D. Coon, et al.. (2011). Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire. Value in Health. 14(8). 1109–1116. 15 indexed citations
15.
Mecklenburgh, J. S., et al.. (2008). Bispectral Index asymmetry and COMFORT score in paediatric intensive care patients. British Journal of Anaesthesia. 100(5). 690–696. 18 indexed citations
16.
Price, Mark. (2002). Measuring the Fringes of Experience. 8. 9 indexed citations
17.
Price, Mark, et al.. (2001). Recurrent atypical fibroxanthoma of the cheek. American Journal of Otolaryngology. 22(1). 73–75. 13 indexed citations
18.
Price, Mark & Glenn D. Goldstein. (1997). The Use of a Digital Imaging System in a Dermatologic Surgery Practice. Dermatologic Surgery. 23(1). 31–32. 19 indexed citations
19.
Price, Mark & Robert M. Pearl. (1994). Multiagent Pharmacotherapy to Enhance Skin Flap Survival. Annals of Plastic Surgery. 33(1). 52–56. 23 indexed citations
20.
Price, Mark, Leonard H. Goldberg, & Moise L. Levy. (1994). Juvenile Basal Cell Carcinoma. Pediatric Dermatology. 11(2). 176–177. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Jia Breakdown of academic impact, for papers by Yo Han Lee Breakdown of academic impact, for papers by Hiroyuki Sakamaki Breakdown of academic impact, for papers by Dingyun You Breakdown of academic impact, for papers by Hang Fu Breakdown of academic impact, for papers by Pensée Wu Breakdown of academic impact, for papers by Zhigang Wu Breakdown of academic impact, for papers by Lauren Collins Breakdown of academic impact, for papers by Ewelina Biskup
Rankless by CCL
2026